Israel’s Immunai expands strategic tie with AstraZeneca

Israeli company Immunai, a developer of AI-based tools for improving drug discovery processes, has announced a strategic agreement with pharmaceuticals company AstraZeneca. Immunai will receive $18 million from AstraZeneca at the…